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A B S T R A C T
Regeneration of a severely damaged cornea necessitates the delivery of both epithelium-renewing limbal epi-
thelial stem cells (LESCs) and stroma-repairing cells, such as human adipose-derived stem cells (hASCs).
Currently, limited strategies exist for the delivery of these therapeutic cells with tissue-like cellular organization.
With the added risks related to suturing of corneal implants, there is a pressing need to develop new tissue
adhesive biomaterials for corneal regeneration. To address these issues, we grafted dopamine moieties into
hydrazone-crosslinked hyaluronic acid (HA-DOPA) hydrogels to impart tissue adhesive properties and facilitate
covalent surface modiﬁcation of the gels with basement membrane proteins or peptides. We achieved tissue-like
cellular compartmentalization in the implants by encapsulating hASCs inside the hydrogels, with subsequent
conjugation of thiolated collagen IV or laminin peptides and LESC seeding on the hydrogel surface. The en-
capsulated hASCs in HA-DOPA gels exhibited good proliferation and cell elongation, while the LESCs expressed
typical limbal epithelial progenitor markers. Importantly, the compartmentalized HA-DOPA implants displayed
excellent tissue adhesion upon implantation in a porcine corneal organ culture model. These results encourage
sutureless implantation of functional stem cells as the next generation of corneal regeneration.
1. Introduction
Millions of people worldwide suﬀer from corneal blindness [1,2].
Severe corneal blindness resulting from thermal or chemical burns, is
characterized by the loss of limbal epithelial stem cells (LESCs), the
tissue-resident stem cells of the cornea, which leads to chronic in-
ﬂammation, overgrowth of blood vessels and conjunctival cells, as well
as stromal scarring [3,4]. Currently, these is no treatment available for
these patients, as they require the implantation of new functional stem
cells for long-term regeneration of the cornea [3,5]. For restoring vi-
sion, controlled regeneration of both corneal epithelium and stroma is
necessary. Although autologous and allogenic primary LESCs from
healthy donor eyes have been widely studied for epithelial regenera-
tion, the supply of isolated stem cells is scarce [6]. With the advance-
ments in stem cell technologies, high quantities of clinically relevant
LESCs can be obtained through diﬀerentiation from human embryonic
stem cells (hESC-LESCs) or induced pluripotent stem cells (iPSCs) for
corneal epithelial regeneration [7–10]. For stromal regeneration, one of
the most promising cell sources are human adipose stem cells (hASCs),
due to their capacity to mitigate inﬂammation and diﬀerentiate into
corneal stromal cells post implantation [11–15]. However, delivery of
two therapeutic stem cell populations compartmentalized in a tissue-
speciﬁc arrangement is a daunting task, which we have previously
sought to solve by using laser-assisted bioprinting [16]. So far, only few
applications have emerged combining diﬀerent cells to regenerate both
the scarred stromal tissue as well as the surface epithelium [17,18], but
their implantation requires suturing, which can increase inﬂammation
and neovascularization of the cornea [2].
Hyaluronic acid (HA) is a naturally occurring polysaccharide, which
can be chemically modiﬁed for many tissue engineering applications,
while being enzymatically cleared in vivo. We have previously shown
the formation of stable HA hydrogels by hydrazone crosslinking be-
tween aldehyde and carbodihydrazide derivatives of HA [19,20]. This
two-component system allows fast gelation and encapsulation of living
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cells for eﬃcient cell delivery [19–22]. In the cornea, native HA has
been shown to induce epithelial cell migration and wound healing, and
it has recently been identiﬁed as an important regulator of the LESC
niche of the cornea, making it an ideal culture substrate for these cells
[23,24]. Despite this, no HA based implantable materials for LESC
transplantation have been previously reported, as corneal cell attach-
ment to HA based ﬁlms has been poor [25]. Injectable HA-based ma-
terials have previously been used for cell delivery to the corneal stroma
[20,26], but these in situ forming hydrogels cannot be used to deliver an
intact epithelial layer. Hence, new implant design is essential for eﬃ-
cient transplantation of distinctly compartmentalized cells to the
cornea, as well as other epithelialized tissues, which require the com-
bination of 3D and 2D cell arrangement.
Sutureless implantation of the hydrogel constructs takes advantage
of the tissue adhesive capability of dopamine, a catecholamine derived
from marine mussels (Mytillus edulis) that functions as a glue in wet
conditions [27,28]. Several in situ forming tissue adhesive hydrogels
based on this catechol chemistry have already been introduced for drug
and cell delivery applications [28–30]. However, these hydrogels are
formed either through self-polymerization of dopamine residues or
metal-coordination polymerization, which both result in the formation
of a strong brown coloration unsuitable for corneal applications
[28–31]. Thus far, the only previously reported tissue adhesive material
with a premade dopamine-containing hydrogel, includes a freeze-dried
dopamine-alginate membrane for general surgery applications [32]. In
corneal regeneration, dopamine residues can potentially have addi-
tional beneﬁts for tissue innervation, as dopamine is a known neuro-
transmitter of corneal nerves [33].
Thus, our ambition was to develop a tissue adhesive scaﬀold for
corneal regeneration with cellular compartmentalization of LESCs on
the surface and hASCs in the hydrogel bulk, promoting regeneration of
both the epithelial and stromal layers upon implantation at the defect
site. We have successfully developed this compartmentalized scaﬀold
and demonstrated the proof-of-concept of sutureless implantation in a
porcine corneal organ culture model, which displayed eﬃcient tissue
integration while retaining the functional characteristics of these stem
cells.
2. Materials and methods
Hyaluronic acid (MW 130 kDa) was purchased from LifeCore
Biomedical (Chaska, USA). Dopamine hydrochloride, 1-ethyl-3-(3-di-
methylaminopropyl)-carbodiimide hydrochloride (EDC), 1-hydro-
xybenzotriazole hydrate (HOBt), Carbodihydrazide (CDH), 3-amino-
1,2-propanediol and sodium periodate, hyaluronidase (from bovine
testes), collagen type IV from human placenta, and 5,5-Dithiobis(2-ni-
trobenzoic acid) (Ellman's reagent) were purchased from Sigma-
Aldrich. Traut's reagent (2-iminothiolane), Zeba™ spin desalting column
(7K MWCO), 0.5M ethylenediaminetetraacetic acid (EDTA, UltraPure),
Dulbecco's modiﬁed Eagle's medium/Ham's nutrient mixture F-12
(DMEM/F-12 1:1), Advanced DMEM, l-glutamine (GlutaMAX™), am-
photericin B, TrypLE™ Select, LIVE/DEAD® viability/cytotoxicity kit,
PrestoBlue® reagent, CyQUANT cell proliferation assay and Molecular
Probes' secondary antibodies were purchased from Thermo Fisher
Scientiﬁc. TaqMan primers for keratocan (KERA, Hs00559942_m1),
lumican (LUM, Hs00929860_m1), aldehyde dehydrogenase 3A1
(ALDH3A1, Hs00964880_m1) and housekeeping gene GAPDH
(Hs99999905_m1), cDNA reverse transcription kit and RNAse free
DNase I for qRT-PCR were purchased from Thermo Fisher Scientiﬁc. For
RNA isolation from hydrogel samples and controls, TRIreagent from
Molecular Research Center Inc. (Cincinnati, OH) and RNeasy Mini Kit
from Qiagen (Qiagen Sollentuna, Sweden) were used. Synthetic la-
minin-derived peptides CDPGYIGSR were obtained from Bachem
(Bubendorf, Switzerland) and Calbiochem (UK). Antibiotics (100
UmL−1 penicillin, 100 μgmL−1 streptomycin) and Dulbecco's phos-
phate buﬀered saline (DPBS) were purchased from Lonza (Basel,
Switzerland). Cell culture media CnT-30 and CnT-Prime-CC were pur-
chased from CELLnTECH (Bern, Switzerland), and human serum (type
AB male, HIV tested) from BioWest (Nuaillé, France). Spectra Por-3
dialysis membrane (MWCO 3500 gmol−1) used for puriﬁcation was
purchased from Spectrum Lab, USA. All solvents were of analytical
quality. Spectrophotometric analyses were carried out on Shimadzu
UV-3600 plus UV-VIS-NIR spectrophotometer or PerkinElmer Lambda
35 UV/VIS spectrophotometer.
2.1. Synthesis and preparation of hydrogels
2.1.1. Synthesis of dopamine modiﬁed hyaluronic acid (HA-DA)
1mmol of HA (400mg, 1 equivalent) was dissolved in 60mL
deionized water, to which 1mmol HOBt (153mg, 1 equivalent) and
1mmol dopamine (190mg, 1 equivalent) was then added. The pH of
the reaction solution was adjusted to 5.5 with 1M HCl and 1M NaOH.
Then 0.25mmol EDC (48mg, 0.25 equivalent) was added in 2 batches
at 30min interval. pH of the solution was maintained at 5.5 for 6 h, and
then allowed to stir overnight. The reaction mixture was loaded into a
dialysis bag and dialyzed against dilute HCl (pH=3.5) containing
100mM NaCl (4×2 L, 24 h) followed by dialysis in dilute HCl (pH 3.5,
2× 2 L, 24 h) and then dialyzed against deionized water (2× 2 L,
24 h). The solution was lyophilized to obtain HA-DA. Degree of dopa-
mine conjugation was 14.4% (with respect to the disaccharide units of
HA) as estimated by NMR spectroscopy (1H NMR, 300MHz). The de-
gree of modiﬁcation was estimated by calculating the ratio of the N-
acetyl peak of HA at 2.0 ppm and the aliphatic protons from dopamine
at 2.42 or 2.72 ppm. This estimation was in agreement with the aro-
matic protons of dopamine between 6.7 and 7.3 ppm (Fig. S1 in Sup-
plementary Information).
2.1.2. Synthesis of HA-CDH conjugate
The conjugation of carbodihydrazide (CDH) on hyaluronic acid was
carried out by carbodiimide coupling chemistry following our pre-
viously reported protocol [19]. The degree of hydrazide modiﬁcations
was found to be 10% (with respect to the disaccharide repeat units), as
determined by trinitrobenzene sulfonic acid (TNBS) assay [34].
2.1.3. Synthesis of HA-DA-CDH conjugate
The conjugation of carbodihydrazide (CDH) on dopamine-modiﬁed
hyaluronic acid (HA-DA) was carried out following the same procedure
as reported for the synthesis of HA-CDH conjugates. Brieﬂy, 0.5mmol
of HA-DA (200mg, 1 equivalent) was dissolved in 120mL of deionized
water. Thereafter, 0.375mmol CDH (34mg, 0.75 equivalent) and
0.5 mmol HOBt (76.5mg, 1 equivalent) was added to the aqueous HA-
DA solution. The pH of the reaction mixture was adjusted to 4.7.
Finally, 0.1 mmol EDC·HCl (20mg, 0.2 equivalent) was added and al-
lowed to stir overnight. The reaction mixture was dialyzed and lyo-
philized, as described above. The degree of hydrazide modiﬁcations
was found to be 10% (with respect to the disaccharide repeat units) as
determined using TNBS assay [34].
2.1.4. Synthesis of HA-Aldehyde (HA-Ald)
The HA-Ald was synthesized following our previously developed
procedure, as described in Ref. [35]. The percentage of aldehyde
modiﬁcation in HA was found to be 10% (with respect to the dis-
accharide units) as determined by 1H NMR spectroscopy. The mod-
iﬁcation degree was estimated by treating HA-Ald with tert-butyl car-
bazate followed by NaCNBH3 reduction (Fig. S2 in Supplementary
Infromation) [35].
2.2. Preparation of hydrogels
The hydrogels were prepared using conventional hydrazone cross-
linking chemistry. The individual components were sterilized with UV
for 30min and dissolved to concentration 16mgmL−1 (w/v), HA-Ald
L. Koivusalo, et al. Biomaterials 225 (2019) 119516
2
and HA-DA-CDH in sterile DPBS and HA-CDH in sterile 10 wt% sucrose
solution. The hydrogels were prepared by mixing the hydrazide com-
ponent (either HA-CDH or HA-DA-CDH) with HA-Ald in equal volumes.
In cell-containing hydrogels, hASCs were suspended in the hydrazide
component prior to mixing, at a concentration of 2×106 cells mL−1.
2.3. Rheological studies
Rheological characterization of the hydrogels was performed to
understand the structure-property relationship caused by hydrogel
crosslinking chemistry using TA instruments’ DHR-II rheometer. Both
amplitude and frequency sweep tests were performed to analyze the
mechanical properties of the hydrogels. During an amplitude sweep, the
amplitude of the deformation was varied while the frequency was kept
constant at 1 Hz, to determine the linear viscoelastic region (LVR).
Subsequent frequency sweep tests were performed between 0.1 and
10 Hz using a constant strain within the LVR, which was 1% in HA-HA
and HA-DOPA gels. For the analysis, the storage and loss modulus were
plotted against the frequency (Hz).
The distance between two crosslinks or entanglement points, i.e. the
average mesh size (ξ), and average molecular weight between cross-
links (Mc) were calculated based on rubber elastic theory that can be
applied on hydrogels with elastic character. Average mesh size, ξ, was











where Gʹ is storage modulus of the hydrogel, N is the Avogadro con-
stant (6.023× 1023mol−1), R is the molar gas constant (8.314 J
K−1mol−1) and T is the temperature (298 K). Average molecular weight







where c is the polymer concentration (1.6% w/v), ρ is the density of
water at 298 K (997 kgm−3), R is the molar gas constant (8.314 J
K−1mol−1), T is the temperature (298 K) and Gʹp is the peak value of Gʹ.
DHR-II TA instruments’ rheometer was also used to quantify the
diﬀerences in adhesion properties between HA-HA gels and HA-DOPA
gels using a tack adhesion test. We ﬁrst glued a piece of porcine cornea
on the top head of the 12mm parallel plate and placed a fully cured gel
of 2mm thickness at the bottom parallel plate. Subsequently, the probe
(cornea tissue) was placed in contact with the gel, with a holding period
of 120 s where a constant force of 100mN was applied. Thereafter, an
axial force of 5 N was applied to separate the probe and the gel at a
constant separation rate. The experiment was performed in triplicates
and the same probe was used to eliminate the eﬀect of surface rough-
ness and a constant holding period was maintained to establish uniform
molecular contacts between the probe and the gel.
2.4. Swelling and degradation analysis
To determine the swelling and degradation behavior of the hydro-
gels, 100 μL hydrogel samples were prepared into cut 1 mL syringes.
The initial weight of the samples was recorded and the samples were
then submerged in DPBS, hASC culture medium (DMEM/F-12 + 5%
human serum) or 20–50 U mL−1 hyaluronidase solution. The residual
mass of the samples in hyaluronidase were recorded at time points 2 h,
4 h, 6 h, 24 h, 48 h (2 days), 72 h (3 days), and 96 h (4 days) until the
samples had degraded. The degradation study was performed for three
parallel samples. The hydrogel samples in DPBS and medium were
weighed after 6 h, and on following days for a total of three weeks. The
swelling measurement was conducted on four parallel samples. The
swelling ratio (SR) for the samples was calculated from the recorded
weight (W) based on Equation (3)





The transparency of the hydrogels was analyzed based on trans-
mittance properties as well as visual evaluation. The transmittance was
measured by preparing the hydrogels in 550 μL micro-cuvettes (light
path 10mm) and measuring their transmittance using a UV/VIS spec-
trophotometer at wavelengths ranging from 380 to 900 nm, using an
empty cuvette (air) as blank. Transmittance was measured from three
independent samples. Visual transparency was evaluated from 150 μL
hydrogel samples prepared in 10mm diameter molds. The hydrogel
samples were removed from their molds, placed on pieces of text, and
photographed from above in natural lighting.
2.6. Conjugation of basement membrane proteins
Covalent surface modiﬁcation of the hydrogels was performed using
synthetic laminin-derived peptide CDPGYIGSR and collagen type IV
(col IV). Prior to conjugation, the laminin-derived peptide was dis-
solved in 5% acetic acid at 1mgmL−1, and col IV in 0.25% acetic acid
at 2mgmL−1. The ﬁnal concentrations on hydrogel surfaces were
2 μg cm−2 for the laminin peptide, and 5 μg cm−2 for col IV. The acidic
peptide and protein solutions were brought to pH 8 using 1M NaOH
right before conjugation. Based on the molar concentration of amine
groups in col IV (148 μM as determined by TNBS assay), 10-fold molar
concentration (1.48mM) of Traut's reagent was used to convert amines
in col IV to thiol groups according to manufacturer's instructions. The
thiolated col IV (col IV-SH) was puriﬁed using a desalting column with
7K MWCO. The concentration of thiols in the ﬁnal products was
quantiﬁed using Ellman's reagent. Thiolated col IV and unmodiﬁed col
IV were added to the HA-DOPA and HA-HA hydrogels at a concentra-
tion of 5 μg cm−2, in PBS pH 8.5 containing 1mM EDTA, and allowed
to react at 37 °C for 2 h. Hydrogels without col IV were used as controls.
The hydrogels were washed 5×5min with DPBS prior to seeding
hESC-LESCs on their surface.
2.7. Quantiﬁcation of thiol groups
The reaction kinetics of the conjugation reaction and the quantiﬁ-
cation of thiol groups in thiolated col IV were measured using Ellman's
reagent. Reaction kinetics were measured using the laminin-derived
peptide CDPGYIGSR, which contains only one thiol group in the N-
terminal cysteine residue per molecule. The reaction kinetics mea-
surement was performed for the same peptide obtained from two dif-
ferent manufacturers, Bachem and Calbiochem. For quantitation of
reaction kinetics, Ellman's reagent was added to the conjugation solu-
tion in equal molarity to the amount of peptide. The peptide solution (at
a concentration of 2 μg cm−2) was pipetted to the gels on a 96-well
plate (100 μL per well) and allowed to react for 1 h at RT. The rest of
the reaction solution was left as a control to account for the dimeriza-
tion of the Cys-terminated peptides. Every 10 min, the absorbance of
the sample from the hydrogels and from control solution at 412 nm was
recorded using the UV/VIS spectrophotometer in 1 mL cuvettes (950 μL
of PBS pH 8.5 + 50 μL sample). To calculate the progress of the re-
action, the absorbance of the control solution was subtracted from the
absorbance of the sample. Reaction kinetics measurement was per-
formed once for each manufacturer's peptide.
The amount of thiol groups of the col IV-SH was quantiﬁed using the
molar absorptivity of Ellman's reagent. 4 mgmL−1 solution of Ellman's
reagent was prepared in reaction buﬀer (0.1M PBS, pH 8.0, containing
1mM EDTA). Two tubes were prepared with 1.25mL of reaction buﬀer
and 25 μL of the Ellman's reagent, and added with 125 μL of either the
col IV-SH sample or pure reaction buﬀer, which served as the blank.
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After 15min, the absorbance of the sample was measured at 412 nm
against the blank using the UV/VIS spectrophotometer. The con-
centration of thiol groups was calculated based on the molar extinction
coeﬃcient of Ellman's reagent (14 150M−1cm−1) and Equation (4)
=c A
bE (4)
where A is the absorbance of the sample at 412 nm, b is the length of the
light path (1 cm), and E is the molar extinction coeﬃcient.
2.8. Cell culture and in vitro analysis
All cell studies were conducted with approval from the Ethics
Committee of the Pirkanmaa Hospital District (Tampere, Finland)
under the approval number R15161 for use of adipose stem cells in
research and approval number R05116 to derive, culture, and diﬀer-
entiate hESC lines for research. The hASCs were isolated from adipose
tissue samples from a female donor during elective plastic surgery at
Tampere University Hospital (Tampere, Finland) under patient's
written consent, as described previously [36,37]. The ﬂow cytometric
cell characterization proﬁle of the hASCs used in this study is described
elsewhere [20]. The hASCs were cultured in a medium containing
DMEM/F-12 supplemented with 5% human serum, 1% GlutaMAX™ and
1% antibiotics. The cells were maintained in T175 cell culture ﬂasks at
37 °C in 5% CO2, and passaged using TrypLE™ Select. Cells were
maintained up to passage 4 prior to encapsulation in hydrogels. For
encapsulation, hASCs were detached from cell culture ﬂasks, collected
by centrifugation and counted. The required number of cells for each
hydrogel was collected in Eppendorf tubes, and the cells were pelleted.
Supernatant was removed and cell pellets were mixed by thorough
pipetting into the hydrazide component (HA-CDH or HA-DA-CHD) at a
concentration of 2× 106 cells mL−1. The hydrogels were then formed
by mixing the cell-containing hydrazide component with an equal vo-
lume of HA-Ald in either 24-well cell culture inserts (Merck Millipore),
total volume of 100 μL, or custom-made polydimethylsiloxane (PDMS)
molds with 10mm diameter wells, total volume of 200 μL. The hydro-
gels were allowed to gel for 2 h in a humid atmosphere at RT before
adding medium. The cell-laden hydrogels were then cultured either in
hASC medium (for 3D cell survival determination) or CnT-Prime-CC
(for co-culture of hASCs and hESC-LESCs) at 37 °C in 5% CO2. To create
the compartmentalized stem cell implants, the hASCs were cultured
alone for 24 h before conjugation of col IV-SH and seeding of hESC-
LESCs.
The hESC-LESCs were diﬀerentiated from human embryonic stem
cell line Regea08/017 cultured in feeder-free conditions, according to
our previously published protocols [38,39]. The hESC-LESCs were
thawed from cryostorage to the basement membrane protein-con-
jugated hydrogels in a concentration of 0.9–1.5×106 cells cm−2, with
further culture of the cell-laden hydrogel in CnT-30 medium containing
0.5% antibiotics. For surface attachment study, hESC-LESCs were cul-
tured on the hydrogels for seven days. The hydrogel scaﬀolds con-
taining both hASCs and hESC-LESCs were cultured in CnT-30 medium
for two to ﬁve days before transplantation in the porcine organ culture
model or ﬁxation for histological evaluation.
The viability of hESC-LESCs on the surface-modiﬁed hydrogels was
evaluated based on cell morphology, with light microscope images
taken with Zeiss Axio Vert A1 (Carl Zeiss AG, Jena, Germany), and
compared quantitatively using PrestoBlue® reagent. For PrestoBlue®
analysis of cell metabolism, three parallel samples were analyzed for
each condition. The samples were washed once with DPBS, and the
PrestoBlue® reagent, diluted 1:10 (v/v) in CnT-30 medium, was added
to the samples. The samples were incubated for 30min at 37 °C, after
which 2× 100 μL samples of the medium were collected on a 96-well
plate. The ﬂuorescence values for the medium samples were measured
using Viktor 1420 Multilabel Counter (Wallac, Turku, Finland) at
544 nm excitation and 590 emission wavelengths.
For hASCs encapsulated into the hydrogels, viability was evaluated
qualitatively using LIVE/DEAD® viability/cytotoxicity kit, and quanti-
tatively with CyQUANT cell proliferation kit and PrestoBlue® after 1, 3,
7 and 10 days. For Live/Dead staining, the hydrogels were removed
from their molds, washed with DPBS and incubated with Live/Dead
staining solution containing 2 μM Calcein AM and 1 μM Ethidium
homodimer diluted in DPBS in 37 °C for 30–45min. The samples were
washed once, and imaged using Olympus IX51 ﬂuorescence microscope
equipped with a DP71 camera (Olympus Corporation, Tokyo, Japan).
For CyQUANT analysis of hydrogel DNA content, three gels with hASCs
and one blank gel were collected in each time point to 2mL Eppendorf
tubes and frozen in −80 °C. After thawing, 100 μL of the CyQUANT
lysis buﬀer was added to the samples, which were then mechanically
homogenized using an Ultra-Turrax disperser (IKA Labortechnik,
Staufen, Germany). Samples were centrifuged at 8000 g for 30 s to re-
move any remaining hydrogel, with the ﬁnal sample diluted 1:10 in
CyQUANT lysis buﬀer. The diluted samples were then pipetted to 96-
well plates with CyQUANT Dye, and the ﬂuorescence was read at 480/
520 nm with Victor 1420 Multilabel Counter microplate reader. For cell
number quantitation, the measured ﬂuorescence values were compared
to a reference standard curve created from 2D cultured hASCs.
PrestoBlue® analysis from encapsulated hASCs was conducted as de-
scribed previously in Ref. [20]. Statistical testing of the cell viability
results was performed by two-way ANOVA between HA-DOPA and HA-
HA gels using GraphPad Prism v5.02.
2.9. Porcine corneal organ culture
Porcine eyes were obtained from a local abattoir. The eyes were
kept in cold DPBS containing 2% antibiotics for up to 4 h before dis-
section and transfer to the organ culture. The eyes were processed as
previously described, and cultured partially submerged in CnT-Prime-
CC medium with 1% antibiotics and 0.1% amphotericin B [20]. Prior to
implantation of the cell-laden hydrogels, an epithelium defect was in-
duced by applying a circular Whatman paper impregnated with 1M
NaOH on the cornea surface for 40 s, followed by rinsing with DPBS and
epithelial scraping. For hydrogel implantation, the organ-cultured
corneas were immobilized on a Barron artiﬁcial anterior chamber
(Katena products Inc., Denville, NJ, USA), where a partial depth inci-
sion was made to the stroma using a 5-mm trephine, from which the
stromal button was excised. The hydrogel implant containing hASCs
and hESC-LESCs was cut to size using a 5-mm trephine, and the implant
was transferred to the stromal wound using a ﬂat spatula. After hy-
drogel implantation, the corneas were transferred to 6-well plates,
covered with soft contact lenses and cultured for additional seven days
in CnT-30 medium at 37 °C, 5% CO2.
To determine the diﬀerentiation potential of implanted hASCs in the
corneal organ culture, 50 μL HA-HA and HA-DOPA gels with en-
capsulated hASCs (300 000 cells/gel) were made directly into the
stromal wounds, with four replicates of each gel. The corneas were
cultured for 10 days in keratocyte diﬀerentiation medium (KDM) con-
taining Advanced DMEM supplemented with 10 ngmL−1 basic ﬁbro-
blast growth factor (bFGF), 0.1 mM ascorbic acid-2-phosphate and 1 μM
retinoic acid, as described previously in Refs. [11,40]. The gels with
cells were collected from the corneal wounds after the culture period
into TRIreagent, and the samples were homogenized using Bioruptor
sonicator (Diagenode SA, Belgium) (30 s ON, 30 s OFF, 2 cycles). RNA
from the samples was isolated by adding chloroform to the TRIreagent
solution, vortexing and centrifugation (12 000 g for 10min). The upper
chloroform phase was collected to a new tube and isopropanol was
added, followed by vortex and centrifugation (12 000 g, 10min). The
supernatant was removed, and the RNA pellet was eluted into 70%
ethanol, vortexed and centrifuged (12 000 g, 10min). The supernatant
was removed and remaining pellet was air-dried and eluted into 30 μl
RNAse free water. The amount of RNA was quantitated using NanoDrop
spectrophotometer (Thermo Fisher Scientiﬁc). Enough RNA to perform
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qRT-PCR was obtained from three replicates for both gels, and the RNA
was treated with DNAse I and transcribed to cDNA using High capacity
cDNA reverse transcription kit (Applied Biosystems, Thermo Fisher
Scientiﬁc). As a control, 2D diﬀerentiation of hASCs was performed on
standard tissue culture plastic 6-well plates, culturing them in KDM for
10 days. Control samples of undiﬀerentiated hASCs and 2D diﬀer-
entiation were collected for quantitative real-time polymerase chain
reaction (qRT-PCR) with Qiagen RNeasy Mini Kit according to manu-
facturer's instructions, and transcribed to cDNA together with RNA
from the gel samples. qRT-PCR analysis for three corneal keratocyte
markers, keratocan (KERA), lumican (LUM) and aldehyde dehy-
drogenase 3A1 (ALDH3A1) was run with Applied Biosystems real time
PCR instrument. The relative fold change of gene expression was ana-
lyzed using the 2−ΔΔCt method.
2.10. Histological analysis and immunoﬂuorescence
For histological analysis, the porcine organ culture corneas were
ﬁxed using 4% paraformaldehyde (PFA) for 3 h at RT, submerged in
Tissue-Tek OCT (Sakura Finetek Europe) at 4 °C overnight, and snap-
frozen in liquid nitrogen. 8mm thick sections were cut from the sam-
ples and air dried for 1 h at RT. Cell-laden hydrogel samples were si-
milarly processed, with 30min ﬁxation in 4% PFA. Sections from the
porcine corneas were then immunohistochemically stained against
human cell surface marker TRA-1-85 to detect implanted human cells.
2.5% normal horse serum (Vector ImmPress reagent, Vector
Laboratories Inc.) was used to block unspeciﬁc binding. Samples were
then labeled overnight at 4 °C with primary mouse IgG antibody TRA-1-
85 (courtesy of Peter Andrews, University of Sheﬃeld) diluted 1:100
(v/v) in 0.5% bovine serum albumin (BSA). Intrinsic peroxide activity
was blocked by incubating the samples with 3% H2O2 for 10 min at RT,
followed by labelling with Vector ImmPress horse anti-mouse IgG
(containing horseradish peroxidase) for 30 min at RT. The antibody
labelling was visualized by peroxidation reaction using
DAB + chromogen system (Dako North America, Inc., Carpinteria, CA,
USA), which was performed for 30 s at RT. The tissue was counter-
stained using Mayer's hematoxylin, followed by dehydration, and
mounting using Coverquick mounting medium (VWR, Helsinki,
Finland). Samples were imaged using Hamamatsu NanoZoomer S60
(Hamamatsu Photonics Norden, Kista, Sweden) whole slide scanner,
and images were obtained using NDP.view2 viewing software.
Immunoﬂuorescence staining, for hESC-LESCs on top of hydrogels
and the transverse cryosections of the cell-laden hydrogels, was carried
out using primary antibodies against p63α, p40, cytokeratin 12 (CK12),
and col IV. Details of the antibodies are listed in Table 1. The hydrogel
samples on well plates were ﬁxed with 4% PFA for 30min at RT, fol-
lowed by washing with DPBS. The samples were then permeabilized
using 0.1% Triton X-100 for 15min, followed by blocking with 3% BSA
and incubation with primary antibodies diluted in 1% BSA overnight at
4 °C. After washing with DPBS, the samples were incubated with
ﬂuorescently labeled secondary antibodies (Table 1) diluted in 1% BSA,
for 1 h at RT. The samples were then washed and mounted under cov-
erslips using mounting medium containing 4′,6-Diamidino-2-Pheny-
lindole (DAPI) (Vectashield® from Vector Laboratories or ProLong™
Gold from Thermo Fisher Scientiﬁc) and imaged using Olympus IX51
ﬂuorescence microscope. Fluorescent images were converted to color
images and adjusted for contrast and brightness using Photoshop.
3. Results and discussion
3.1. Synthesis and characterization of dopamine-functionalized HA
hydrogel
We have previously developed hydrazone-based robust hydrogels
using HA-aldehyde (HA-Ald) and HA-carbodihydrazide (HA-CDH) with
exceptional enzymatic stability and swelling characteristics [19]. We
used this two-component biorthogonal system for fabricating the
compartmentalized cellular scaﬀold for corneal applications. In order to
introduce the tissue adhesive properties to facilitate sutureless im-
plantation of the scaﬀold, we conjugated L-dopamine moiety in the
polymer. The degree of dopamine functionalization was 14%, as de-
termined by 1H NMR (Fig. S1 in Supplementary Information). The al-
dehyde and CDH groups were grafted on HA following our previously
optimized carbodiimide protocol [19] and the percentage of aldehyde
and CDH functionalization was around 10% (with respect to the dis-
accharide repeat units), which was quantiﬁed by 1H NMR (Fig. S2 in
Supporting Information) and UV/VIS spectroscopy. We utilized HA gels
with similar aldehyde and CDH modiﬁcation without dopamine units as
the control group. The dopamine-functionalized HA-gels were desig-
nated as HA-DOPA, while the control gel was designated as HA-HA.
Their structures are presented in Fig. 1.
3.2. HA-HA and HA-DOPA gels display highly elastic character
We performed rheological evaluation to estimate the viscoelastic
properties of HA-HA and HA-DOPA gels by measuring the gel de-
formation following the frequency sweep method. The gels were sub-
jected to strain sweep to determine the linear viscoelastic region (LVR)
of the hydrogel, followed by a frequency sweep test at 0.1–10 Hz using
a constant strain within the LVR (Fig. 2a). The gels showed storage
moduli (G′) of 898.81 ± 16.46 Pa and 619.57 ± 13.02 Pa and loss
moduli (G′′) of 3.046 ± 0.07 Pa and 1.88 ± 0.624 Pa respectively for
HA-HA and HA-DOPA gels. The storage modulus G′ was consistently
higher than the loss modulus G′′ throughout the screened frequency
range suggesting that both the hydrogels were stable and possessed
viscoelastic properties. The tan δ, which represents the ratio of storage
and loss moduli, was found to be signiﬁcantly less than 1 (0.0034 and
0.0030 for HA-HA and HA-DOPA gels respectively) suggesting a highly
elastic character for these gels. By using the modulus data, we estimated
the average mesh size ξ (representing the distance between the en-
tanglement points or probable pore size) and the average molecular
weight between the crosslinksMc by using the rubber elastic theory that
can be applied to highly elastic hydrogels [41]. These calculations re-
vealed that average mesh size ξ was 16.6 nm and 18.8 nm while the Mc
was 41.46 kgmol−1 and 56.96 kgmol−1 for HA-HA and HA-DOPA gels
respectively. Thus, HA-HA gel was stiﬀer and more compact than the
HA-DOPA gel, with smaller ξ and Mc.
Next, we investigated the eﬀect of encapsulated stem cells on the
Table 1
Antibodies used for immunoﬂuorescence staining.
Antibody Host Supplier catalog no. dilution [v/v]
p63α rabbit Cell Signaling Technology 4892 1:200
p40 mouse Biocare Medical 3066 1:100
CK12 goat Santa Cruz Biotechnology sc-17099 1:200
collagen IV goat Millipore AB769 1:200
anti-rabbit Alexa-488 donkey Molecular Probes A21206 1:800
anti-goat Alexa-568 donkey Molecular Probes A11057 1:800
anti-mouse Alexa-647 donkey Molecular Probes A31571 1:800
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viscoelastic properties of the scaﬀold (Fig. 2b). We cultured hASCs in
HA-HA and HA-DOPA gels (2×106 cells mL−1) for 24 h as described in
section 2.8. After that, the cell-laden hydrogels were extracted from
their molds and we performed the rheological measurements as de-
scribed in section 2.3. We found that the encapsulation of cells within
the hydrogel resulted in the reduction of storage modulus (G′) for both
HA-HA and HA-DOPA gels. This could be attributed to two factors, the
presence of diﬀerent serum proteins and biomolecules in the cell cul-
ture medium and the cell surface proteins. The gels showed storage
moduli G′ of 309.15 ± 5.63 Pa and 483.70 ± 7.35 Pa and loss moduli
G″ of 6.94 ± 1.71 Pa and 11.00 ± 1.69 Pa respectively for HA-HA and
HA-DOPA gels at the frequency of 1 Hz. Interestingly, when we com-
pare the two gels formulated in PBS to the gels formulated with cells in
cell culture medium we observed that the change in G′ was smaller in
Fig. 1. Chemical structures of hydrazone-crosslinked HA-DOPA (a) and HA-HA (b) hydrogels.
Fig. 2. Material characterization of HA-DOPA and HA-HA gels. a) Rheological measurement of G′ and G′′ in the frequency sweep mode. b) Frequency sweep of G′ and
G′′ of hydrogels with encapsulated hASCs. c) Hydrogel swelling ratios in PBS. d) Hydrogel swelling ratios in cell culture medium. e) Enzymatic degradation of the
hydrogels in the presence of hyaluronidase. f) Adhesion force measurement of the hydrogels to corneal surface.
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HA-DOPA gels when compared to HA-HA gels. The G′ decreased with
the incorporation of cells in HA-HA gels from 898.81 ± 16.46 Pa to
309.15 ± 5.63 Pa, and in HA-DOPA from 619.57 ± 13.02 Pa to
483.70 ± 7.35 Pa. This observation indicates that the dopamine units
form some kind of interpenetrating network or exert adhesive forces
that prevent the swelling and disruption of molecular crosslinks. This is
further evidenced by the average mesh size ξ values for both gels. In the
presence of cells, HA-DOPA and HA-HA had average mesh size
20.41 nm and 23.7 nm respectively, while without cells the values were
18.8 nm and 16.6 nm, respectively. This means that the HA-DOPA gel
had a larger pore size in PBS, whereas in the presence of cells, the
average mesh size was reduced, presumably due to adhesive forces
exerted by the dopamine moiety. The tan δ was found to be less than 1
(0.0224 and 0.0227 for HA-HA and HA-DOPA gels respectively) sug-
gesting elastic characteristics for these gels, but the degree of elasticity
was much lower in the presence of cells compared to the gels without
encapsulated cells (tan δ 0.0034 and 0.0030 for HA-HA and HA-DOPA
gels respectively). Thus, in the presence of cells, HA-DOPA gels were
stiﬀer and more compact with smaller ξ and Mc than HA-HA gels. The
material characteristics are summarized in Table 2.
For the cornea, the material property most often described is the
shear modulus. The shear modulus of the native cornea varies with
depth, with the anterior stroma having a higher modulus (7.71 kPa)
than the deeper parts of the cornea (1.31–1.99 kPa) [42]. Although our
application focuses on replacing the anterior stromal part of the cornea
with the hydrogel scaﬀold, we consider the mismatch of the initial
mechanical properties of the material to the cornea to be incon-
sequential for the ﬁnal regenerative target. For stable corneal re-
generation and integration, the stromal cells should secrete their own
extracellular matrix (ECM) and remodel their environment. This has
been previously shown during a 4-year follow-up of cell-free stromal
implants composed of densely crosslinked collagen hydrogels, where
surrounding stromal cells were seen to slowly replace the implant with
stromal tissue [43]. Our approach aims at faster remodeling and in-
tegration of the scaﬀold to the corneal tissue through encapsulation of
hASCs.
3.3. HA-DOPA gel shows good swelling stability in physiological conditions
To evaluate the swelling property of the HA-HA and HA-DOPA gels,
we measured their weight increase in phosphate buﬀered saline (PBS,
pH 7.4) and cell culture medium at 37 °C (Fig. 2c and d). Both gels
showed similar swelling behavior, but the swelling kinetics diﬀered in
PBS compared to cell culture medium. In PBS, the hydrogels reached an
equilibrium swelling state after 1 week, whereas in medium, the hy-
drogels continued to swell in a linear manner throughout the mea-
surement period. In PBS, both gels displayed an initial 20% burst in
swelling upon hydration, after which the swelling slowed down and
subsequently leveled at approximately 34% for HA-HA and 50% for
HA-DOPA during three weeks. The higher swelling ratio of HA-DOPA
gel may be associated with the larger average mesh size, which allows
more water permeability inside the hydrogel network. Interestingly, in
medium, the swelling ratio for HA-HA surpassed that of HA-DOPA after
the 1-week time point, ultimately reaching 110% for HA-HA and 85%
for HA-DOPA in three weeks. We believe the sustained swelling prop-
erties of the two hydrogels in cell culture medium are attributed to the
dynamic nature of the hydrazone bond, which may undergo exchange
with proteins present in the medium. Lower swelling in medium ob-
served for HA-DOPA may indicate that the hydrazone bond dynamics
are complemented by additional interpenetrating crosslinks introduced
by dopamine self-polymerization or adhesive forces exerted by dopa-
mine, which was supported by a slight increase in intensity of the slight
brown hue of HA-DOPA gels during prolonged exposure to cell culture
medium, as discussed in detail in Section 3.5.
Hydrazone crosslinking using CDH-derived hydrazones has been
shown to be considerably more stable than hydrazone crosslinks from
other hydrazides, due to the resonance stabilization eﬀect across the
hydrazone bond [19]. The engraftment of dopamine residues to HA
increased the PBS swelling capacity of the gels, indicating that the in-
corporation of dopamine slightly hindered the crosslinking eﬃcacy of
the gels. Conversely, the HA-DOPA gels were more stable in medium,
which arguably resembles the in vivo environment more closely than
PBS, indicating their overall suitability for tissue engineering applica-
tions. However, in the cornea, the tissue environment is not as dilute as
the conditions of the swelling study. In vivo, the hydration of corneal
tissue is maintained by the pumping mechanism of the endothelium,
and the surface of the cornea is wetted by tear ﬂuid secreted by the
lacrimal and Meibomian glands and the goblet cells of the conjunctiva,
with its varying composition of lipids, proteins and small molecules
[44]. The actual swelling of the implants in the intended application
should hence be studied in a more tissue-speciﬁc environment.
We studied the in vitro degradation kinetics of the hydrogels in the
presence of hyaluronidase (HAse), a ubiquitous enzyme known for the
in vivo degradation of HA. At a concentration of 20–50 UmL−1 of HAse,
both HA-HA and HA-DOPA gels displayed complete digestion in 96 h
(Fig. 2e). Although, the concentration of HAse used in this experiment
is not directly comparable to that in the eye, the enzymatic degradation
of the scaﬀold implies that the chemical modiﬁcations on the HA-HA
and HA-DOPA gels did not disrupt the native bioactivity and the bio-
degradability of the polymer. For ﬁnal applications, the rate of de-
gradation in vivo should be studied further to match the regeneration of
the replaced corneal tissue, which can take from months to even years
to complete [45].
3.4. HA-DOPA adheres strongly to the corneal surface
Adhesion of biomaterial scaﬀold to the defect site is of paramount
importance for successful tissue regeneration. Scaﬀolds bearing alde-
hyde functional groups are known to display tissue adhesive properties
[46]. However, as the aldehyde functional groups are utilized for hy-
drazone crosslinking, the free aldehyde residues are not suﬃcient en-
ough to provide the adhesiveness required for scaﬀold integration. We
anticipated that incorporation of dopamine groups would further aug-
ment the adhesive properties of the scaﬀold. We conjugated 14.4%
dopamine units on the HA backbone, as the overall HA modiﬁcation
(hydrazide and dopamine moiety) must not exceed 25% [47] in order to
preserve the biodegradability and activity of the biopolymer.
We performed a rheometric tack adhesion test to quantify the ad-
hesion properties of HA-HA gels and HA-DOPA gels with the corneal
surface. Although both HA-HA and HA-DOPA gels displayed some ad-
hesion properties, HA-DOPA clearly showed greater adhesion to the
cornea with cohesive failure between the probe and the gel. This can be
Table 2
Material properties of HA-DOPA and HA-HA gels.
Hydrogel n ′G [Pa] ″G [Pa] ′ ″tan δ[G /G ] ξ [nm] −M  [kg mol ]C 1
HA-HA 3 898.81 ± 16.46 3.046 ± 0.07 0.0034 16.6 41.46
HA-DOPA 3 619.57 ± 13.02 1.88 ± 0.624 0.0030 18.8 56.96
HA-HA with cells 3 309.15 ± 5.63 6.94 ± 1.71 0.0224 23.7 123.27
HA-DOPA with cells 3 483.70 ± 7.35 11.00 ± 1.69 0.0227 20.41 79.38
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seen from Fig. 2f, as more negative force was required to separate the
probe and the gel surface.
3.5. Hydrogels display excellent transparency for corneal applications
Transparency is a key property of any biomaterial used for corneal
applications. The native cornea exhibits light transmission of 90–95%
in wavelengths ranging from 600 to 1000 nm [48]. To analyze the
transparency of the hydrogels, we measured the transmittance of light
over the visible light spectrum (380–900 nm), shown in Fig. 3a. Both
hydrogels showed over 90% light transmittance over the whole visible
spectrum. Interestingly, transmittance values for HA-DOPA
(98 ± 2.39%) measured even higher than for HA-HA (95 ± 4.64%).
This indicates that the slight brown hue caused by the DOPA residues,
seen in Fig. 3b, did not seem to hinder the transmittance of light
through the HA-DOPA gel, whereas the lower transmittance of HA-HA
might be caused by minute inhomogeneity of the gel occurring through
mixing of the sucrose-dissolved HA-CDH component and HA-Ald dis-
solved in PBS.
The brown coloration is a distinct trait of dopamine-containing
materials. As dopamine residues self-polymerize, they display an in-
tense brown color [49]. Dopamine-functionalized hydrogels reported so
far generally rely on self-polymerization reaction or metal-coordination
for eﬀective crosslinking [28–31]. However, in our hydrogel implants,
the dopamine residues are not responsible for the crosslinking, leaving
them free to participate in the surface modiﬁcation and tissue-adhesion
of the preformed hydrogel implant. This results in a transparent hy-
drogel, which is suitable for corneal applications. Further in vivo studies
are warranted to assess the impact of dopamine functionalization and
transparency on the regenerated corneal tissue.
3.6. Immobilization of cell adhesive factors enables cellular
compartmentalization in tissue adhesive hydrogels
One major limitation of HA-based hydrogels for 3D cell culture is
the poor cell adhesion due to the lack of binding sites for integrins, the
major mediators of cell adhesion to the ECM. However, the en-
capsulated cells can probe their microenvironment and secrete ECM
making it conducive for cell growth and diﬀerentiation [50,51]. To
achieve cellular compartmentalization of the two stem cell populations,
we conjugated cell adhesive peptides and proteins on the surface, ex-
ploiting the Michael acceptor characteristics of the dopamine residue.
Our ﬁrst choice of cell adhesive molecule was a cysteine-terminated
laminin-derived synthetic peptide (CDPGYIGSR) which could be cova-
lently grafted to the surface of the hASC-encapsulated hydrogel. This
laminin-derived peptide contains the cell adhesion motif YIGSR, which
has been previously shown to have signiﬁcant potential for improving
primary corneal epithelial cell adhesion to biomaterial surfaces [52].
Furthermore, recombinant laminin is an integral component of the
culture substrate for the diﬀerentiation and culture of hESC-LESCs [38].
Ellman's quantitation of free thiols (Fig. 4) revealed that the conjuga-
tion reaction initially progressed rapidly, and reached a plateau after
10–20min. Comparison of the same peptide from diﬀerent manu-
facturers produced similar reaction kinetics, while the Bachem peptide
conjugation reaction progressed further until approximately 70% of the
peptide were bound to the surface, and was thus selected for the cell
attachment study. Although we could achieve excellent conjugation of
the laminin peptide on to the preformed hydrogels by Michael addition
reaction, we could obtain only sparsely distributed hESC-LESCs on
these peptide-modiﬁed surfaces (Fig. 5h). Subsequently, another com-
ponent of hESC-LESC culture substrate, human collagen type IV (col IV)
was chosen as the preferential basement membrane protein. Col IV was
thiolated using 2-iminothiolane (Traut's reagent) to col IV-SH with the
necessary reactive groups for Michael addition. The conversion of pri-
mary amines in col IV to thiol groups, as determined by Ellman quan-
titation assay, was found to be 57 ± 4.2% in this study.
The hESC-LESCs cultured on col IV-SH conjugated HA-DOPA sur-
faces displayed eﬃcient cell adhesion and better long-term cell viability
than on similarly treated HA-HA (Fig. 5). Interestingly, we observed
some degree of hESC-LESCs attachment even when unmodiﬁed col IV
was coated on the HA-DOPA gels (Fig. 5e-g) indicating the adhesive
tendency of dopamine-functionalized surfaces. Also the HA-HA control
gel also displayed some binding of col IV-SH (Fig. 5i-k). This may be
attributed to the dynamic nature of the hydrazone bond, allowing the
thiol-containing peptides or proteins to undergo thiazolidine cross-
linking with aldehyde groups available on the scaﬀolds [53]. The mi-
croscopic evaluation of cell morphology was supported by the Pre-
stoBlue® cell viability measurement (Fig. 5q-r), which shows that
initially the hESC-LESCs attach on both gel types, but there is a gradual
Fig. 3. Transmittance and transparency HA-DOPA and HA-HA gels. a) Transmittance of light at diﬀerent wavelengths through the hydrogels. b) Transparency of the
hydrogels illustrated by photography of HA-DOPA (upper) and HA-HA (lower) gels on text.
Fig. 4. Reaction kinetics measurement of surface conjugation of Cys-terminated
laminin-derived peptide. The reaction progress was calculated based on the
presence of free thiol groups in the reaction solution at diﬀerent time points.
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loss of cells from the HA-HA gels, resulting in a signiﬁcantly higher cell
viability on HA-DOPA at day 7. The immunoﬂuorescence staining for
col IV in hydrogel cross-sections, shown in Fig. 6a, veriﬁed the presence
of high amounts of col IV on the col IV-SH-conjugated HA-DOPA, but
only very little on HA-HA at 2 days after conjugation.
The cells grown on the HA-DOPA gels for 7 days showed appro-
priate protein expression for progenitor-type hESC-LESCs, as shown in
Fig. 6b. The continued expression of the limbal stem cell marker
ΔNp63α, which was conﬁrmed by the co-labelling of p63α and p40 in
cell nuclei, together with the low expression levels of epithelial ma-
turation marker cytokeratin 12 (CK12) indicated that the hESC-LESCs
retained their progenitor-like phenotype after 1 week of culture on
these substrates. The hESC-LESCs still present on col IV-SH-conjugated
HA-HA gels after 7 days also retained similar marker expression, al-
though the portion of ΔNp63α-positive cells was smaller than on HA-
DOPA. This suggests that covalent conjugation of the protein is indis-
pensable on the hydrogel surface for the continued growth and main-
tenance of hESC-LESCs.
Fig. 5. Morphology and viability of hESC-LESCs on surface-modiﬁed hydrogels. a-c) hESC-LESCs seeded on thiolated col IV (col IV-SH)-immobilized HA-DOPA after 1
day, 3 days and 7 days of culture, respectively. The same time points are also shown for HA-DOPA with non-thiolated col IV (e–g) and col IV-SH on HA-HA (i–k) and
non-thiolated col IV on HA-HA (m–o). Images d) and l) represent hESC-LESC morphology observed on unmodiﬁed HA-DOPA and HA-HA surfaces, respectively.
Images h) and p) are representative images of hESC-LESCs 2 days after plating on laminin-derived peptide –immobilized HA-DOPA and HA-HA, respectively. Graphs
q) and r) show the PrestoBlue® viability measurements of hESC-LESCs on col IV –modiﬁed hydrogel surfaces at day 1 and day 7, respectively. Scale bars in images are
200 μm ** denotes statistical signiﬁcance at p < 0.01.
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Fig. 6. Covalent surface conjugation of col IV-SH enables the existence of two distinctly organized human stem cell types in the hydrogels. a) Fluorescent staining of
col IV at the surface of HA-DOPA and HA-HA gels 2 days after conjugation, the dotted line represents the surface of the hydrogel. b) hESC-LESCs cultured on col IV-
SH-conjugated HA-DOPA and HA-HA for 7 days express the limbal stem cell markers p63α and p40, with low expression of epithelial diﬀerentiation marker CK12. c)
Live/Dead staining of hASCs inside hydrogels at diﬀerent time points, live cells are shown in green, and dead cells in red. d) CyQUANT results representing the
number of hASCs in the gels during culture. e) PrestoBlue® quantitation metabolic activity of hASCs inside gels during culture. f) Relative gene expression of hASCs
10 days after implantation to ex vivo corneal model and 2D control condition showed increased expression of lumican, an extracellular matrix component of the
cornea. Values reﬂect fold changes in mRNA expression over undiﬀerentiated hASCs. Scale bars in images a) and b) are 200 μm, in c) 500 μm *** denotes statistical
signiﬁcance at p < 0.001. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the Web version of this article.)
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The encapsulated hASCs remained viable within the HA-DOPA and
HA-HA gels for 2 weeks of culture, as presented in Fig. 6c. The Live/
Dead staining shows only few dead cells, whereas the amount of live
cells remains high throughout the culture period, with slightly more
cells in the HA-DOPA gels than the HA-HA. Furthermore, within the
HA-DOPA gels hASCs occurred mostly as single cells or small groups of
cells with some apparent elongation, whereas in HA-HA more rounded
cell clustering was observed. This observation is interesting as HA gels
lack integrin binding sites and the cells cultured in these gels tradi-
tionally show rounded morphology. We hypothesize that the adhesive
nature of the DOPA residues in HA-DOPA gels may promote entrapment
of the endogenous ECM produced by the cells, thus promoting cell
elongation within these gels. In accordance with our results, me-
senchymal stem cells within hydrogels have been shown to produce
very rapidly a cell-type speciﬁc ECM around themselves, through which
they interact with the surrounding hydrogel [51].
The CyQUANT results, shown in Fig. 6d, for assessing the number of
cells within the HA-DOPA and HA-HA gels also indicate higher hASC
viability and proliferation within the HA-DOPA gels than in HA-HA in
all time points, with signiﬁcantly higher number of cells on day 10.
However, the PrestoBlue® results (Fig. 6e) of cells’ metabolic activity
within the gels show less pronounced diﬀerence between the groups.
Overall, the HA-DOPA gels were superior to HA-HA gels in terms of cell
growth of both hESC-LESCs and hASCs.
3.7. HA-DOPA gels support sutureless implantation in porcine corneal organ
culture
As a proof-of-concept in using the tissue adhesive hydrogel implants
for delivering epithelial and stromal regenerating cells to the cornea,
we performed an anterior lamellar keratoplasty procedure (i.e. removal
of part of the outer stroma) in an ex vivo cornea organ culture model
with excised porcine corneas. We transplanted the approximately 2mm
thick hydrogel implants into the created stromal wounds, without uti-
lizing additional means of securing the implants in place. Due to the
ﬁtted trephination of both the wound and the implant, as well as the
static nature of the subsequent organ culture, all implants remained in
place for the duration of the culture. However, during manipulation of
the corneas for ﬁxation and histology, some HA-HA implants were ex-
truded from the wounds (example shown in Fig. S3 in Supplementary
Information). All HA-DOPA implants remained well attached, and in
tight contact with the surrounding stromal tissue. After 7 days of cul-
ture, immunohistochemical staining against the human cell surface
marker TRA-1-85 showed the presence of human cells both on the
surface of the hydrogels as well as inside them (Fig. 7). However, we
did not observe signiﬁcant outgrowth of hASCs to the corneal stroma or
migration of the hESC-LESCs out from the implant during this 1-week
culture period. This outcome could be improved with further optimi-
zation of the implantation techniques to achieve better alignment of the
implant surface with the surface of the cornea. However, we anticipate
that the remodeling of the implant by the encapsulated and surrounding
cells during stromal regeneration would ultimately take care of small
mismatches in surface alignment between the implant and the corneal
surface.
To investigate the diﬀerentiation potential of implanted hASCs in
the corneal organ culture model, we adapted a method used previously
for implantation of hASCs to corneal stromal wounds with HA-hydro-
gels, as described in Ref. [20], with known in vitro diﬀerentiation
methods of hASCs to corneal keratocytes [11,40]. By culturing the
porcine corneas with hASCs delivered in HA-DOPA or HA-HA in kera-
tocyte diﬀerentiation medium for 10 days, we analyzed the expression
of three marker genes of corneal keratocyte diﬀerentiation by qRT-PCR
compared to undiﬀerentiated hASCs. However, only one of the studied
genes, lumican, was detected in satisfactory amounts after this culture
period in ex vivo cultured hASCs as well as the 2D diﬀerentiation con-
trol (Fig. 6f). The expression of lumican in the ex vivo diﬀerentiated
hASCs was similarly increased in HA-DOPA and HA-HA, while the ex-
pression in both gels was slightly lower than that in the 2D condition.
Lumican is a small leucine rich proteoglycan aiding in ECM organiza-
tion, abundantly expressed by corneal keratocytes. However, as lu-
mican is not solely expressed by corneal cells, the diﬀerentiation of
hASCs towards corneal keratocytes was not conclusively veriﬁed in this
study. Despite the inconclusive keratocyte diﬀerentiation, the results
suggest the 3D ex vivo diﬀerentiation capacity of these cells to be si-
milar to the 2D control condition. This further strengthens the rationale
behind this work, as the scope of our research focuses on the delivery of
these undiﬀerentiated cells to the corneal stroma, where their ther-
apeutic capacity in vivo has been clinically demonstrated [14,15].
Based on these results, the corneal organ culture method provides
the practical utility of the HA-DOPA gels as a sutureless stem cell de-
livery method for corneal regeneration and encourages to proceed to-
wards in vivo studies for further evaluation of the therapeutic func-
tionality of these stem cell-containing tissue adhesive implants.
4. Conclusions
In this study, we fabricated an implantable tissue adhesive hydrogel
scaﬀold for the delivery of spatially compartmentalized therapeutic
stem cells for simultaneous regeneration of the corneal stroma and
epithelium, with encapsulated hASCs in the hydrogel bulk and hESC-
LESCs on the surface. Dopamine moieties grafted to the hyaluronic acid
hydrogel imparted the tissue adhesive function, facilitated the con-
jugation of cell-adhesive proteins to the hydrogel surface and supported
hASC culture. Furthermore, incorporation of dopamine moieties aug-
mented the cell viability, improved the mechanical properties and re-
duced hydrogel swelling in presence of cell culture medium. Using this
sophisticated delivery system, we established the proof-of-concept of
implanting two regenerative stem cell types in the cornea using a
porcine corneal organ culture model, demonstrating its potential as an
implantable tissue-engineered construct for corneal applications. We
believe that our study represents the ﬁrst sutureless delivery of any cells
to the surface of the eye, as well as the ﬁrst sutureless delivery system of
two diﬀerentially localized cell populations to any tissue.
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